about
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stressClinical Relevance of Biomarkers of Oxidative StressPharmacology and Clinical Drug Candidates in Redox MedicineReactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical IndicationsBad News: Analysis of the Quality of Information on Influenza Prevention Returned by Google in English and Italian.Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent SecretionMIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitmentProtection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitorsChlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitroAdding Dimensions to the Analysis of the Quality of Health Information of Websites Returned by Google: Cluster Analysis Identifies Patterns of Websites According to their Classification and the Type of Intervention DescribedThe oxidative stress theory of disease: levels of evidence and epistemological aspects.Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomicsGlutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systemsRedox regulation of cyclophilin A by glutathionylation.Activities of erythropoietin on tumors: an immunological perspective.Online Information on Antioxidants: Information Quality Indicators, Commercial Interests, and Ranking by Google.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Gene expression profiling reveals a signaling role of glutathione in redox regulation.Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal.IL-1 family nomenclature.Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.Cardiac protection by pharmacological modulation of inflammation.Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDSNeuroprotective properties of epoetin alfa.Tumor necrosis factor and motoneuronal degeneration: an open problem.Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.Redox regulation of chemokine receptor expressionAsialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.Redox proteomics: identification of oxidatively modified proteins.Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice.Erythropoietin both protects from and reverses experimental diabetic neuropathy.Redox proteomics of the inflammatory secretome identifies a common set of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and oxidative stress.Tumor necrosis factor as a pharmacological target.Erythropoietin as an antiapoptotic, tissue-protective cytokine.The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats.Hyperresponsive febrile reactions to interleukin (IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient miceErythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke.Redox proteomics: identification and functional role of glutathionylated proteins.Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation.
P50
Q24611053-35931066-1A93-48F8-B000-4D0F2B49C815Q26785512-F2529579-785A-4707-92A2-D79FBD85B9C3Q26785525-D09BD0F6-8713-4D68-A146-AB7D79A66D7BQ27024762-591CF289-8710-46EF-8379-D70E3FE1A845Q27329610-565C3DBC-50B5-4069-9068-04660A3C942BQ28257763-3E4329E9-674D-41B5-AB37-4D1F30E70721Q28298072-6EFF854A-EFD7-4592-91A8-BB87B074A824Q28341723-3C4B5D1C-31C7-437C-9854-4856024CFFE6Q28378754-C7E8267A-6472-42A9-A04B-D086657DEEE8Q28608514-7D6A20C7-22DB-4AD8-806C-3D4F18484377Q30489579-A6C5A9EB-4F72-4EDF-98A3-B8EEA26174FCQ31031108-D2B34CDF-387B-4BE6-B4C3-F81C8A0A7665Q31096762-2395EF11-01CD-4B87-9063-CF5A935328A1Q33230144-C6E979A6-9A10-493F-AE31-A497EFC98864Q33344041-09D03070-2640-40A6-A691-1D6418E0152DQ33586117-3505ECE6-CF4D-4F2B-B763-4192A6E5D769Q33761211-BED085D0-2D24-4F9B-A94F-1B455CFCB468Q34048072-793B5B58-393C-4251-99DD-79C9B1197F79Q34082980-C0E9AE8C-1D5E-4A79-BBF6-9FC8D1DB4F6BQ34144622-7D1621BF-7428-4B22-9B6B-030B4867A658Q34419957-B9C8D225-F949-4800-87B3-D3E00C6B8196Q34481804-2EC8DB92-FBEB-4C56-973A-F4917F63C608Q34484677-8134BD15-297D-4F5B-8280-3B46FB7EA70CQ34506947-404F0239-C639-458E-8403-1A5713AEF843Q34533100-35F7E1BE-2719-4581-B2C8-E93C93E4C44EQ34596211-4CD882DC-962F-41F2-B489-D1806B4EF326Q34960679-A2501833-634A-4FBE-90B1-B4FDCD3F88D8Q35081123-B23C854F-0B1C-4AF6-A3DC-A7C6808B2183Q35144156-E6DBACBE-BF90-449E-8544-B30400E06EA0Q35181893-2B4DB4D3-7B73-469D-9726-84796C69B041Q35403268-E0CC243E-F181-44DA-B507-8F410B59C1A8Q35554405-3641F5FB-6629-42F0-9282-12C170518167Q35634273-1DA5BC7B-1474-4C62-A736-B478E375C23DQ35738215-6E52266D-95C6-406D-8D17-34EBFF4F3CCFQ35831214-07ECB71E-7114-48A4-B34A-2C36F282A77FQ35844081-05D18E87-AB50-4920-BE45-1FA10C656574Q36055032-644E9DCC-2C01-4F79-B551-5FBE9EFB7767Q36066188-17C65C8D-9D9E-481C-AB98-E4B88A75541BQ36168403-B0FE04D7-9147-4A81-AC02-6D42C839050FQ36184166-0671377E-291A-44A8-A8C0-560590E868C7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Pietro Ghezzi
@ast
Pietro Ghezzi
@en
Pietro Ghezzi
@es
Pietro Ghezzi
@nl
Pietro Ghezzi
@sl
type
label
Pietro Ghezzi
@ast
Pietro Ghezzi
@en
Pietro Ghezzi
@es
Pietro Ghezzi
@nl
Pietro Ghezzi
@sl
prefLabel
Pietro Ghezzi
@ast
Pietro Ghezzi
@en
Pietro Ghezzi
@es
Pietro Ghezzi
@nl
Pietro Ghezzi
@sl
P1006
P214
P244
P1006
P106
P21
P213
0000 0001 1560 2627
P214
P244
P2798
P31
P496
0000-0003-0911-8358
P734
P735
P7859
lccn-n00120387